Vanguard Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $750M | Sell |
|
|||||
|
2025
Q1 | $772M | Sell |
|
|||||
|
2024
Q4 | $854M | Buy |
|
|||||
|
2024
Q3 | $850M | Buy |
|
|||||
|
2024
Q2 | $1.04B | Buy |
|
|||||
|
2024
Q1 | $1.01B | Sell |
|
|||||
|
2023
Q4 | $784M | Buy |
|
|||||
|
2023
Q3 | $584M | Sell |
|
|||||
|
2023
Q2 | $591M | Sell |
|
|||||
|
2023
Q1 | $500M | Sell |
|
|||||
|
2022
Q4 | $573M | Sell |
|
|||||
|
2022
Q3 | $436M | Sell |
|
|||||
|
2022
Q2 | $449M | Sell |
|
|||||
|
2022
Q1 | $512M | Sell |
|
|||||
|
2021
Q4 | $690M | Buy |
|
|||||
|
2021
Q3 | $599M | Sell |
|
|||||
|
2021
Q2 | $570M | Sell |
|
|||||
|
2021
Q1 | $544M | Sell |
|
|||||
|
2020
Q4 | $465M | Buy |
|
|||||
|
2020
Q3 | $367M | Sell |
|
|||||
|
2020
Q2 | $338M | Sell |
|
|||||
|
2020
Q1 | $273M | Sell |
|
|||||
|
2019
Q4 | $316M | Buy |
|
|||||
|
2019
Q3 | $310M | Buy |
|
|||||
|
2019
Q2 | $239M | Buy |
|
|||||
|
2019
Q1 | $207M | Buy |
|
|||||
|
2018
Q4 | $165M | Buy |
|
|||||
|
2018
Q3 | $174M | Buy |
|
|||||
|
2018
Q2 | $76.2M | Buy |
|
|||||
|
2018
Q1 | $43.2M | Buy |
|
|||||
|
2017
Q4 | $43.3M | Buy |
|
|||||
|
2017
Q3 | $33.3M | Buy |
|
|||||
|
2017
Q2 | $29.4M | Buy |
|
|||||
|
2017
Q1 | $24.6M | Buy |
|
|||||
|
2016
Q4 | $26.4M | Buy |
|
|||||
|
2016
Q3 | $2.84M | Buy |
|